['H]-Thymidine incorporation correlated well with morphologic evidence of lymphoproliferation. The mechanism of the inhibitory effect of type IV or V hyperlipoproteinemic plasma upon the response tested was not identified but may be related to interaction between lipoproteins and the cell membranes. We suggest that these lipoproteins may also interfere with the function of other cells.
INTRODUCTION
Primary type IV hyperlipoproteinemia is characterized by elevated plasma concentrations of very low density lipoproteins (VLDL) ' and is associated with an inThis material was presented in part at the Southern Section meeting of the American Federation for Clinical Research, 30 January 1975, New Orleans, La.
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creased risk of atherosclerosis (1, 2) . Type V hyperlipoproteinemia is characterized by elevated plasnma levels of VLDL and chylomicrons and is associated with an increased risk of developing l)ancreatitis (3) . An undue susceptibility to infections or manifestations of imnmunologic impairment have not been associated with either lipid transport disorder.
We wish to report that plasma from patients having a type IV or type V hyperlipoproteinemic pattern inhibits proliferation by cultured mononuclear leukocytes (MNL) when stinmulated with mitogens or antigens.
This inhibition was identified with both VLDL and chylomicrons; patient lymphocytes responded normally after they were waslhed and then cultured in medium containing normal plasma. METHODS 10 patients with type IV and 10 patients with type V primary hyperlipoproteinemia (Table I) MNL were separated from heparinized blood by floatation on Ficoll-Hypaque (9). Triplicate cultures were prepared in flat-bottomed microtiter plates (Linbro Chemical Co., New Haven, Conn.) and incubated for 7 days (except where specified otherwise). Our leukocyte culture technique, the preparation of mitogens and antigens, and the method employed to measure [3H]thymidine incorporation have been described elsewhere in detail (10) (11) (12) . Proliferative stimuli tested included phytohemagglutinin (PHA) (Difco Laboratories, Detroit, Mich.), pokeweed mitogen (Grand Island Biological Co., Grand Island, N. Y.), dialyzed C. albicans and freshly reconstituted streptokinase-streptodornase. Stimulation in the mixed leukocyte reaction was with 2 X 105 MNL-lymphocytes per culture shortly after exposure to 2,500 R of X-irradiation.
[3H] Thymidine incorporation in unstimulated cultures was recorded directly. Net incorporation was recorded in stimulated cultures after subtracting spontaneous incorporation in paired unstimulated cultures.
Proliferative responses to both C. albicanis and streptococcal antigens were measured and the higher net incorporation was recorded as the representative response to soluble antigens.
PHA was labeled with '25I (Na 'SI, Amersham/Searle Corp., Arlington Heights, Ill., sp act approximately 14 mCi/,gg I) by the chloramine T procedure (13 Similar experiments were performed on 10 patients with a type V hyperlipoproteinemic pattern. Cultures were prepared concomitantly on patient MNL and MNL from a healthy subject. Paired cultures were set up on each cell preparation with patient plasmiia and with normal plasma in the medium. Brisk incorporation occurred in stimulated cultures of washed patient and normal MNL when cultured in medium that contained third-party normal plasma (Fig. 1) To evaluate the possibility of significant binding of PHA and [3H]thymidine to the lipoproteins, medium was prepared in the usual fashion with type V hyperlipoproteinemic and with normal plasma. 'I-PHA and ['H]thymidine were added separately in proportions used in MNL cultures. After thorough mixing and 18 h of incubation, the lipoproteins were removed by ultra-centrifugation and passed over an agarose gel column, and the radioactivity in the lipoprotein fraction was determined. The results indicated that less than 0.005% of the lectin and unappreciable amounts of [3H]thymidine remained with the lipoproteins.
DISCUSSION
This study presents evidence that plasma from patients with type IV or V hyperlipoproteinemia decreases proliferation by cultured lymphocytes. The reduction of [3H]thymidine incorporation by cultured MNL stimulated with mitogens or allogeneic leukocyte antigens was quantitatively related to the concentration of VLDL or chylomicrons added to the culture medium. Others have shown that ['H]thymidine incorporation correlates with DNA synthesis by cultured lymphocytes (14) . Low
[3H]thymidine incorporation in stimulated cultures that contained hyperlipoproteinemic plasma correlated with a reduction in lymphoblastogenesis in the present study. Additional experiments showed that the phenomenon observed was not due to shortened survival of cultured MNL or to complexing of PHA or [3H]thymidine to lipoproteins. The most likely explanation for this new observation is that elevated concentrations of VLDL or chylomicrons in culture medium inhibit lymphoproliferation. Our data do not indicate whether these lipoproteins interfere with lymphocytes, macrophages, or both.
The mechanisms involved in the inhibition of lymphoproliferation by these lipoprotein fractions were not defined. Preliminary evidence indicates that 2I-VLDL binds to the mononuclear cell, as has been observed elsewhere with cultured fibroblasts (15) . Perhaps chylomicrons and VLDL inhibit lymphoproliferation by interfering with events at the cell membrane level, presumably by steric hindrance, preventing the normal interaction between stimulus and cell membrane. Alternatively, the composition and properties of the cell membrane may be altered in the presence of the hyperlipidemic plasma. It is also possible that these lipoproteins are internalized by cells (16) , where they may alter metabolic processes. Studies are in progress to determine the mechanisms that produce the effects reported here and to determine whether the intact lipoprotein or the lipid or apoprotein constituents are responsible. The effect of VLDL or chylomicrons upon lymphoproliferation in vitro is reversible by washing patient MNL and then culturing them in medium that contains normal plasma.
Plasma from patients with other disorders has been reported to inhibit proliferative responses by cultured lymphocytes. These disorders include chronic mucocutaneous candidiasis (11, 17) , solid tumors (18, 19) , primary tumors of lymphoid tissues (20, 21) , and systemic lupus erythematosus (22) .
Proliferation by sensitized lymphocytes in response to antigens is a normal correlate of delayed hypersensitivity (23) . Impaired lymphoproliferative responsiveness occurs frequently with various immunodeficiencies (21, (24) (25) (26) . Abnormal plasmas with a type IV or V lipoprotein pattern may interfere with other immune responses as well, particularly those that involve lymphocyte proliferation (27) . The concentration of plasma in our cultures is about half the normal concentration of plasma in the blood. Since inhibition of [3H]thymidine incorporation by VLDL or chylomicrons is concentration dependent, plasma from patients with type IV or V hyperlipoproteinemia may be a more potent inhibitor of immune responses within the circulation than in our in vitro culture system.
Patients with primary type IV or V hyperlipoproteinemia are not clinically immunodeficient. Since lipoproteins are macromolecules (28) , plasma lipoproteins may be largely confined within the vascular bed, analogous to macroglobulins (29) . Immune reactive cells outside the circulatory bed may not be exposed to the high concentrations of lipoproteins present in plasma. The immunobiological significance of our findings may, therefore, relate only to the intravascular compartment.
The possibility of interference with normal immune mechanisms within the vascular bed is suggested by our data. Viral-induced changes in the smooth muscle of blood vessels may have a role in the atherogenic process (30, 31) . Perhaps patients in whom the immune process within blood vessels is suppressed have greater susceptibility to viral-induced changes in the walls of arteries.
If lipoproteins interfere with interactions between proliferative stimuli and MNL membranes, it is also possible that lipoproteins interfere with other important events at the cell surface level (such as hormone bindings). Interference of this type may also involve other cells, such as those that comprise vascular endothelium. The consequences of such alterations of cell membrane function may be highly relevant to the pathogenesis of clinical disorders (such as atherosclerosis) associated with type IV or V primary hyperlipoproteinemia.
